Galapagos’ service companies, BioFocus and Argenta, have entered into a multi-year collaboration with AstraZeneca to find new compounds against key targets in AZ’s research programs in respiratory and inflammatory diseases. BioFocus or Argenta will provide the medicinal chemistry, biology and ADME/PK services, and each AZ project will have access Argenta’s full suite of in vivo respiratory pharmacology models. Financial terms were not disclosed. “Both BioFocus and Argenta have worked extensive...